Drug intelligence / Profile preview

lidocaine + prilocaine

Development stage
Approved
Lead developer
AstraZeneca
Modality
Small Molecules, Drug Delivery Systems
Administration
Topical, Transdermal
01

Overview

Lidocaine + prilocaine is a fixed-dose combination of two amide-type local anesthetics. Both agents act by blocking voltage-gated sodium channels in neuronal cell membranes, thereby inhibiting the initiation and conduction of nerve impulses. This results in reversible local anesthesia (numbing) at the site of application. The combination is most commonly formulated as a topical cream or patch (e.g., EMLA cream), used for dermal anesthesia prior to minor procedures such as intravenous catheter insertion, blood sampling, superficial surgical interventions, skin grafts, laser hair removal, tattooing preparation, and cleansing or debridement of leg ulcers. It can also be used on genital mucosa for minor procedures or to treat premature ejaculation via topical spray formulations[1][6][9]. Onset and duration depend on dose and application time; effective anesthesia typically requires 1–2 hours under occlusion for intact skin[1][6]. Systemic absorption is generally low but increases with larger doses or compromised skin integrity.

Brand names
EmlaPromescentLidocaine and Prilocaine Cream
Other names
利多卡因 + 丙胺卡因lidocaine/prilocaine利多卡因/丙胺卡因
02

Targets

SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)

Beyond the preview

Go deeper on lidocaine + prilocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine + prilocaine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call